Toll-like receptor 4 activation in cancer progression and therapy

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Oblak, Alja ^a,b   Jerala, Roman ^a,b,c  

^a NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^b EN FIST CENTRE OF EXCELLENCE   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CPG OLIGODEOXYNUCLEOTIDE; DENDRITIC CELL VACCINE; ENDOTOXIN; LIGAND; MELANOMA ANTIGEN 3; TOLL LIKE RECEPTOR 4; WART VIRUS VACCINE; ANTINEOPLASTIC AGENT; IMMUNOLOGICAL ADJUVANT; TUMOR ANTIGEN;

BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CARCINOGENESIS; CELL MATURATION; CHRONIC INFLAMMATION; COLON CANCER; DENDRITIC CELL; GLIOMA; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPHOCYTE ACTIVATION; MEDICAL RESEARCH; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; TUMOR IMMUNITY; UTERINE CERVIX CANCER; ANIMAL; DISEASE COURSE; DRUG ANTAGONISM; DRUG POTENTIATION; IMMUNITY; IMMUNOLOGY; IMMUNOTHERAPY; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CANCER VACCINES; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; ENDOTOXINS; HUMANS; IMMUNITY; IMMUNOTHERAPY; NEOPLASMS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84855172987     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/609579     Document Type: Review

References (136)

1. Igney F. H., Krammer P. H., Immune escape of tumors: apoptosis resistance and tumor counterattack Journal of Leukocyte Biology 2002 71 6 907 920
2. Walker P. R., Saas P., Dietrich P. Y., Tumor expression of Fas ligand (CD95L) and the consequences Current Opinion in Immunology 1998 10 5 564 572 (Pubitemid 28479190)
3. Kawai T., Akira S., TLR signaling Cell Death and Differentiation 2006 13 5 816 825
4. Schreibelt G., Tel J., Sliepen K. H. E. W. J., Benitez-Ribas D., Figdor C. G., Adema G. J., De Vries I. J. M., Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy Cancer Immunology, Immunotherapy 2010 59 10 1573 1582
5. Liu H., Komai-Koma M., Xu D., Liew F. Y., Toll-like receptor 2 signaling modulates the functions of CD 4 + CD 25 + regulatory T cells Proceedings of the National Academy of Sciences of the United States of America 2006 103 18 7048 7053
6. Sutmuller R. P. M., den Brok M. H. M. G. M., Kramer M., Bennink E. J., Toonen L. W. J., Kullberg B. J., Joosten L. A., Akira S., Netea M. G., Adema G. J., Toll-like receptor 2 controls expansion and function of regulatory T cells Journal of Clinical Investigation 2006 116 2 485 494 (Pubitemid 43228366)
7. Kabelitz D., Expression and function of Toll-like receptors in T lymphocytes Current Opinion in Immunology 2007 19 1 39 45 (Pubitemid 46084902)
8. Huang B., Zhao J., Li H., He K. L., Chen Y., Mayer L., Unkeless J. C., Xiong H., Toll-like receptors on tumor cells facilitate evasion of immune surveillance Cancer Research 2005 65 12 5009 5014 (Pubitemid 40827306)
9. Kelly M. G., Alvero A. B., Chen R., Silasi D. A., Abrahams V. M., Chan S., Visintin I., Rutherford T., Mor G., TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer Cancer Research 2006 66 7 3859 3868
10. Andreani V., Gatti G., Simonella L., Rivero V., Maccioni M., Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo Cancer Research 2007 67 21 10519 10527 (Pubitemid 350070828)
11. Hashimoto C., Hudson K. L., Anderson K. V., The Toll gene of drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein Cell 1988 52 2 269 279
12. Lemaitre B., Nicolas E., Michaut L., Reichhart J. M., Hoffmann J. A., The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults Cell 1996 86 6 973 983 (Pubitemid 26336801)
13. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M., MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 Journal of Experimental Medicine 1999 189 11 1777 1782 (Pubitemid 29272694)
14. Viriyakosol S., Tobias P. S., Kitchens R. L., Kirkland T. N., MD-2 binds to bacterial lipopolysaccharide Journal of Biological Chemistry 2001 276 41 38044 38051
15. Resman N., Val J., Oblak A., Pristovek P., Gioannini T. L., Weiss J. P., Jerala R., Essential roles of hydrophobic residues in both MD-2 and Toll-like receptor 4 in activation by endotoxin Journal of Biological Chemistry 2009 284 22 15052 15060
16. Park B. S., Song D. H., Kim H. M., Choi B. S., Lee H., Lee J. O., The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex Nature 2009 458 7242 1191 1195
17. Bjrkbacka H., Fitzgerald K. A., Huet F., Li X., Gregory J. A., Lee M. A., Ordija C. M., Dowley N. E., Golenbock D. T., Freeman M. W., The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades Physiological Genomics 2005 19 319 330 (Pubitemid 40039937)
18. Mantovani A., Allavena P., Sica A., Balkwill F., Cancer-related inflammation Nature 2008 454 7203 436 444
19. Hanahan D., Weinberg R. A., The hallmarks of cancer Cell 2000 100 1 57 70 (Pubitemid 30046295)
20. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation Cell 2011 144 5 646 674
21. Grauer O. M., Molling J. W., Bennink E., Toonen L. W. J., Sutmuller R. P. M., Nierkens S., Adema G. J., TLR ligands in the local treatment of established intracerebral murine gliomas Journal of Immunology 2008 181 10 6720 6729
22. Qian Y., Deng J., Xie H., Geng L., Zhou L., Wang Y., Yin S., Feng X., Zheng S., Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling Journal of Cancer Research and Clinical Oncology 2009 135 3 379 386
23. Yang H., Zhou H., Feng P., Zhou X., Wen H., Xie X., Shen H., Zhu X., Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion Journal of Experimental and Clinical Cancer Research 2010 29 1, article 92
24. Tang X. Y., Zhu Y. Q., Wei B., Wang H., Expression and functional research of TLR4 in human colon carcinoma American Journal of the Medical Sciences 2010 339 4 319 326
25. Doan H. Q., Bowen K. A., Jackson L. A., Evers B. M., Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells Anticancer Research 2009 29 7 2473 2478
26. Szczepaski M., Stelmachowska M., Stryczyski., Golusiski W., Samara H., Mozer-Lisewska I., Zeromski J., Assessment of expression of Toll-like receptors 2, 3 and 4 in laryngeal carcinoma European Archives of Oto-Rhino-Laryngology 2007 264 5 525 530 (Pubitemid 46569951)
27. Molteni M., Marabella D., Orlandi C., Rossetti C., Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4 Cancer Letters 2006 235 1 75 83
28. Goto Y., Arigami T., Kitago M., Nguyen S. L., Narita N., Ferrone S., Morton D. L., Irie R. F., Hoon D. S. B., Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors Molecular Cancer Therapeutics 2008 7 11 3642 3653
29. Hassan F., Islam S., Tumurkhuu G., Naiki Y., Koide N., Mori I., Yoshida T., Yokochi T., Intracellular expression of Toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide BMC Cancer 2006 6, article 281
30. Szajnik M., Szczepanski M. J., Czystowska M., Elishaev E., Mandapathil M., Nowak-Markwitz E., Spaczynski M., Whiteside T. L., TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer Oncogene 2009 28 49 4353 4363
31. Zhou M., McFarland-Mancini M. M., Funk H. M., Husseinzadeh N., Mounajjed T., Drew A. F., Toll-like receptor expression in normal ovary and ovarian tumors Cancer Immunology, Immunotherapy 2009 58 9 1375 1385
32. Bronte V., Serafini P., Mazzoni A., Segal D. M., Zanovello P., L-arginine metabolism in myeloid cells controls T-lymphocyte functions Trends in Immunology 2003 24 6 302 306
33. Park S. J., Nakagawa T., Kitamura H., Atsumi T., Kamon H., Sawa S. I., Kamimura D., Ueda N., Iwakura Y., Ishihara K., Murakami M., Hirano T., IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation Journal of Immunology 2004 173 6 3844 3854 (Pubitemid 39280747)
34. Sun R., Tian Z., Kulkarni S., Gao B., IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4 + T cell- and STAT3-dependent manners Journal of Immunology 2004 172 9 5648 5655 (Pubitemid 38542068)
35. Xu M., Mizoguchi I., Morishima N., Chiba Y., Mizuguchi J., Yoshimoto T., Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27 Clinical and Developmental Immunology 2010 2010 9
36. Nishioka Y., Wen H., Mitani K., Robbins P. D., Lotze M. T., Sone S., Tahara H., Differential effects of IL-12 on the generation of alloreactive CTL mediated by murine and human dendritic cells: a critical role for nitric oxide Journal of Leukocyte Biology 2003 73 5 621 629 (Pubitemid 38040475)
37. Koblish H. K., Hunter C. A., Wysocka M., Trinchieri G., Lee W. M. F., Immune suppression by recombinant interleukin (rIL)-12 involves interferon induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect Journal of Experimental Medicine 1998 188 9 1603 1610 (Pubitemid 28516105)
38. Pei Z., Lin D., Song X., Li H., Yao H., TLR4 signaling promotes the expression of VEGF and TGF 1 in human prostate epithelial PC3 cells induced by lipopolysaccharide Cellular Immunology 2008 254 1 20 27
39. Simiantonaki N., Kurzik-Dumke U., Karyofylli G., Jayasinghe C., Michel-Schmidt R., Kirkpatrick C. J., Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer International Journal of Molecular Medicine 2007 20 1 21 29
40. Kanczkowski W., Tymoszuk P., Ehrhart-Bornstein M., Wirth M. P., Zacharowski K., Bornstein S. R., Abrogation of TLR4 and CD14 expression and signaling in human adrenocortical tumors Journal of Clinical Endocrinology and Metabolism 2010 95 12 E421 E429
41. Gonzlez-Reyes S., Marn L., Gonzlez L., Gonzlez L. O., Del Casar J. M., Lamelas M. L., Gonzlez-Quintana J. M., Vizoso F. J., Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis BMC Cancer 2010 10, article 665
42. Schmauer B., Andrulis M., Endrich S., Mller-Hermelink H.-K., Eck M., Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori International Journal of Medical Microbiology 2005 295 3 179 185 (Pubitemid 40776102)
43. Zhang Y. B., He F. L., Fang M., Hua T. F., Hu B. D., Zhang Z. H., Cao Q., Liu R. Y., Increased expression of Toll-like receptors 4 and 9 in human lung cancer Molecular Biology Reports 2009 36 6 1475 1481
44. Gonzlez-Reyes S., Fernndez J. M., Gonzlez L. O., Aguirre A., Surez A., Gonzlez J. M., Escaff S., Vizoso F. J., Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence Cancer Immunology, Immunotherapy 2011 60 2 217 226
45. Pandey R., Misra V., Misra S. P., Dwivedi M., Kumar A., Tiwari B. K., Helicobacter pylori and gastric cancer Asian Pacific Journal of Cancer Prevention 2010 11 3 583 588
46. Ogawa T., Asai Y., Sakai Y., Oikawa M., Fukase K., Suda Y., Kusumoto S., Tamura T., Endotoxic and immunobiological activities of a chemically synthesized lipid A of Helicobacter pylori strain 206-1 FEMS Immunology and Medical Microbiology 2003 36 1-2 1 7 (Pubitemid 36515077)
47. Yokota S. I., Okabayashi T., Rehli M., Fujii N., Amano K. I., Helicobacter pylori lipopolysaccharides upregulate Toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogen-activated protein kinase pathway Infection and Immunity 2010 78 1 468 476
48. Su B., Ceponis P. J. M., Lebel S., Huynh H., Sherman P. M., Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells Infection and Immunity 2003 71 6 3496 3502 (Pubitemid 36637578)
49. Gyde S. N., Prior P., Allan R. N., Stevens A., Jewell D. P., Truelove S. C., Lofberg R., Brostrom O., Hellers G., Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres Gut 1988 29 2 206 217 (Pubitemid 18078890)
50. Eaden J. A., Abrams K. R., Mayberry J. F., The risk of colorectal cancer in ulcerative colitis: a meta-analysis Gut 2001 48 4 526 535 (Pubitemid 32234798)
51. Fukata M., Hernandez Y., Conduah D., Cohen J., Chen A., Breglio K., Goo T., Hsu D., Xu R., Abreu M. T., Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors Inflammatory Bowel Diseases 2009 15 7 997 1006
52. Fukata M., Chen A., Vamadevan A. S., Cohen J., Breglio K., Krishnareddy S., Hsu D., Xu R., Harpaz N., Dannenberg A. J., Subbaramaiah K., Cooper H. S., Itzkowitz S. H., Abreu M. T., Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors Gastroenterology 2007 133 6 1869 e2
53. Greenhough A., Smartt H. J. M., Moore A. E., Roberts H. R., Williams A. C., Paraskeva C., Kaidi A., The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 2009 30 3 377 386
54. Hernandez Y., Sotolongo J., Breglio K., Conduah D., Chen A., Xu R., Hsu D., Ungaro R., Hayes L. A., Pastorini C., Abreu M. T., Fukata M., The role of prostaglandin E2 (PGE 2) in Toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia BMC Gastroenterology 2010 10, article 82
55. Cammarota R., Bertolini V., Pennesi G., Bucci E. O., Gottardi O., Garlanda C., Laghi L., Barberis M. C., Sessa F., Noonan D. M., Albini A., The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker Journal of Translational Medicine 2010 8, article 112
56. Starska K., Forma E., Lewy-Trenda I., Stasikowska O., Bry M., Krajewska W. M., ukomski M., The expression of SOCS1 and TLR4-NF B pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma Folia Histochemica et Cytobiologica 2009 47 3 401 410
57. Wang E. L., Qian Z. R., Nakasono M., Tanahashi T., Yoshimoto K., Bando Y., Kudo E., Shimada M., Sano T., High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer British Journal of Cancer 2010 102 5 908 915
58. Earl T. M., Nicoud I. B., Pierce J. M., Wright J. P., Majoras N. E., Rubin J. E., Pierre K. P., Gorden D. L., Chari R. S., Silencing of TLR4 decreases liver tumor burden in a murine model of colorectal metastasis and hepatic steatosis Annals of Surgical Oncology 2009 16 4 1043 1050
59. Hua D., Liu M. Y., Cheng Z. D., Qin X. J., Zhang H. M., Chen Y., Qin G. J., Liang G., Li J. N., Han X. F., Liu D. X., Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity Molecular Immunology 2009 46 15 2876 2884
60. Gatti G., Quintar A. A., Andreani V., Nicola J. P., Maldonado C. A., Masini-Repiso A. M., Rivero V. E., Maccioni M., Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer Prostate 2009 69 13 1387 1397
61. Kundu S. D., Lee C., Billips B. K., Habermacher G. M., Zhang Q., Liu V., Wong L. Y., Klumpp D. J., Thumbikat P., The Toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells Prostate 2008 68 2 223 229 (Pubitemid 351186234)
62. Yu L., Wang L., Li M., Zhong J., Wang Z., Chen S., Expression of Toll-like receptor 4 is down-regulated during progression of cervical neoplasia Cancer Immunology, Immunotherapy 2010 59 7 1021 1028
63. Pidgeon G. P., Harmey J. H., Kay E., Da Costa M., Redmond H. P., Bouchier-Hayes D. J., The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease British Journal of Cancer 1999 81 8 1311 1317
64. Killeen S. D., Wang J. H., Andrews E. J., Redmond H. P., Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-B-dependent activation of the urokinase plasminogen activator system British Journal of Cancer 2009 100 10 1589 1602
65. Hodgkinson C. P., Laxton R. C., Patel K., Ye S., Advanced glycation end-product of low density lipoprotein activates the Toll-like 4 receptor pathway implications for diabetic atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 12 2275 2281
66. Ji Y. Y., Liu J. T., Liu N., Wang Z. D., Liu C. H., PPAR activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway Biochemical Pharmacology 2009 78 9 1186 1197
67. Ji Y., Liu J., Wang Z., Liu N., Angiotensin II induces inflammatory response partly via Toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells Cellular Physiology and Biochemistry 2009 23 4-6 265 276
68. Biragyn A., Ruffini P. A., Leifer C. A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A. K., Farber J. M., Segal D. M., Oppenheim J. J., Kwak L. W., Toll-like receptor 4-dependent activation of dendritic cells by -defensin 2 Science 2002 298 5595 1025 1029 (Pubitemid 35247310)
69. Biragyn A., Coscia M., Nagashima K., Sanford M., Young H. A., Olkhanud P., Murine -defensin 2 promotes TLR-4/MyD88-mediated and NF- B-dependent atypical death of APCs via activation of TNFR2 Journal of Leukocyte Biology 2008 83 4 998 1008 (Pubitemid 351959881)
70. Schaefer L., Babelova A., Kiss E., Hausser H.-J., Baliova M., Krzyzankova M., Marsche G., Young M. F., Mihalik D., Gtte M., Malle E., Schaefer R. M., Grne H.-J., The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages Journal of Clinical Investigation 2005 115 8 2223 2233 (Pubitemid 41134165)
71. Babelova A., Moreth K., Tsalastra-Greul W., Zeng-Brouwers J., Eickelberg O., Young M. F., Brucker P., Pfeilschifter J., Schaefer R. M., Grne H. J., Schaefer L., Biglycan, a danger signal that activates the NLRP3 inflammasome via Toll-like and P2X receptors Journal of Biological Chemistry 2009 284 36 24035 24048
72. Ehrchen J. M., Sunderktter C., Foell D., Vogl T., Roth J., The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer Journal of Leukocyte Biology 2009 86 3 557 566
73. Fischer H., Ellstrm P., Ekstrm K., Gustafsson L., Gustafsson M., Svanborg C., Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4 Cellular Microbiology 2007 9 5 1239 1251 (Pubitemid 46547141)
74. Smiley S. T., King J. A., Hancock W. W., Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4 Journal of Immunology 2001 167 5 2887 2894 (Pubitemid 32768923)
75. Kuhns D. B., Priel D. A. L., Gallin J. I., Induction of human monocyte interleukin (IL)-8 by fibrinogen through the Toll-like receptor pathway Inflammation 2007 30 5 178 188 (Pubitemid 47573147)
76. Okamura Y., Watari M., Jerud E. S., Young D. W., Ishizaka S. T., Rose J., Chow J. C., Strauss J. F., The extra domain A of fibronectin activates Toll-like receptor 4 Journal of Biological Chemistry 2001 276 13 10229 10233
77. Gondokaryono S. P., Ushio H., Niyonsaba F., Hara M., Takenaka H., Jayawardana S. T. M., Ikeda S., Okumura K., Ogawa H., The extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4 Journal of Leukocyte Biology 2007 82 3 657 665 (Pubitemid 47367158)
78. Park J. S., Svetkauskaite D., He Q., Kim J. Y., Strassheim D., Ishizaka A., Abraham E., Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein Journal of Biological Chemistry 2004 279 9 7370 7377 (Pubitemid 38294612)
79. Jong S. P., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J. Y., Strassheim D., Sohn J. W., Yamada S., Maruyama I., Banerjee A., Ishizaka A., Abraham E., High mobility group box 1 protein interacts with multiple Toll-like receptors American Journal of Physiology 2006 290 3 C917 C924
80. Yu M., Wang H., Ding A., Golenbock D. T., Latz E., Czura C. J., Fenton M. J., Tracey K. J., Yang H., HMGB1 signals through Toll-like receptor (TLR) 4 and TLR2 Shock 2006 26 2 174 179 (Pubitemid 44162504)
81. Mittal D., Saccheri F., Vénéreau E., Pusterla T., Bianchi M. E., Rescigno M., TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells The EMBO Journal 2010 29 13 2242 2252
82. Ohashi K., Burkart V., Flohé S., Kolb H., Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex Journal of Immunology 2000 164 2 558 561 (Pubitemid 30043672)
83. Asea A., Rehli M., Kabingu E., Boch J. A., Baré O., Auron P. E., Stevenson M. A., Calderwood S. K., Novel signal transduction pathway utilized by extracellular HSP70. Role of Toll-like receptor (TLR) 2 and TLR4 Journal of Biological Chemistry 2002 277 17 15028 15034 (Pubitemid 34952579)
84. Vabulas R. M., Ahmad-Nejad P., Ghose S., Kirschning C. J., Issels R. D., Wagner H., HSP70 as endogenous stimulus of the toll/interleukin-1 receptor signal pathway Journal of Biological Chemistry 2002 277 17 15107 15112 (Pubitemid 34952589)
85. de Graaf R., Kloppenburg G., Kitslaar P. J. H. M., Bruggeman C. A., Stassen F., Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4 Microbes and Infection 2006 8 7 1859 1865 (Pubitemid 44128888)
86. Johnson G. B., Brunn G. J., Kodaira Y., Platt J. L., Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4 Journal of Immunology 2002 168 10 5233 5239 (Pubitemid 34495991)
87. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C., Simon J. C., Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4 Journal of Experimental Medicine 2002 195 1 99 111 (Pubitemid 34074500)
88. Taylor K. R., Trowbridge J. M., Rudisill J. A., Termeer C. C., Simon J. C., Gallo R. L., Hyaluronan fragments stimulate endothelial recognition of injury through TLR4 Journal of Biological Chemistry 2004 279 17 17079 17084 (Pubitemid 38560463)
89. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., Prestwich G. D., Mascarenhas M. M., Garg H. G., Quinn D. A., Homer R. J., Goldstein D. R., Bucala R., Lee P. J., Medzhitov R., Noble P. W., Regulation of lung injury and repair by Toll-like receptors and hyaluronan Nature Medicine 2005 11 11 1173 1179 (Pubitemid 43093664)
90. Taylor K. R., Yamasaki K., Radek K. A., Di Nardo A., Goodarzi H., Golenbock D., Beutler B., Gallo R. L., Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2 Journal of Biological Chemistry 2007 282 25 18265 18275 (Pubitemid 47100227)
91. Gariboldi S., Palazzo M., Zanobbio L., Selleri S., Sommariva M., Sfondrini L., Cavicchini S., Balsari A., Rumio C., Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of -defensin 2 via TLR2 and TLR4 Journal of Immunology 2008 181 3 2103 2110
92. Shimada M., Yanai Y., Okazaki T., Noma N., Kawashima I., Mori T., Richards J. S., Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR 2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization Development 2008 135 11 2001 2011 (Pubitemid 351943364)
93. Miller Y. I., Viriyakosol S., Binder C. J., Feramisco J. R., Kirkland T. N., Witztum J. L., Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells Journal of Biological Chemistry 2003 278 3 1561 1568 (Pubitemid 36801384)
94. Miller Y. I., Viriyakosol S., Worrall D. S., Boullier A., Butler S., Witztum J. L., Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 6 1213 1219 (Pubitemid 40776611)
95. Bae Y. S., Lee J. H., Choi S. H., Kim S., Almazan F., Witztum J. L., Miller Y. I., Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: Toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2 Circulation Research 2009 104 2 210 218
96. Vogl T., Tenbrock K., Ludwig S., Leukert N., Ehrhardt C., Van Zoelen M. A. D., Nacken W., Foell D., Van Der Poll T., Sorg C., Roth J., Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock Nature Medicine 2007 13 9 1042 1049 (Pubitemid 47517513)
97. Walton K. A., Hsieh X., Gharavi N., Wang S., Wang G., Yeh M., Cole A. L., Berliner J. A., Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl- sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8: a role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein Journal of Biological Chemistry 2003 278 32 29661 29666 (Pubitemid 36962351)
98. Imai Y., Kuba K., Neely G. G., Yaghubian-Malhami R., Perkmann T., van Loo G., Ermolaeva M., Veldhuizen R., Leung Y. H. C., Wang H., Liu H., Sun Y., Pasparakis M., Kopf M., Mech C., Bavari S., Peiris J. S. M., Slutsky A. S., Akira S., Hultqvist M., Holmdahl R., Nicholls J., Jiang C., Binder C. J., Penninger J. M., Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury Cell 2008 133 2 235 249 (Pubitemid 351512299)
99. Park H. D., Lee Y., Oh Y. K., Jung J. G., Park Y. W., Myung K., Kim K. H., Koh S. S., Lim D. S., Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation Oncogene 2011 30 201 211
100. Sandri S., Rodriguez D., Gomes E., Monteiro H. P., Russo M., Campa A., Is serum amyloid A an endogenous TLR4 agonist? Journal of Leukocyte Biology 2008 83 5 1174 1180 (Pubitemid 351960349)
101. Shi H., Kokoeva M. V., Inouye K., Tzameli I., Yin H., Flier J. S., TLR4 links innate immunity and fatty acid-induced insulin resistance Journal of Clinical Investigation 2006 116 11 3015 3025 (Pubitemid 44684486)
102. Guillot L., Balloy V., McCormack F. X., Golenbock D. T., Chignard M., Si-Tahar M., Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4 Journal of Immunology 2002 168 12 5989 5992 (Pubitemid 34620010)
103. Midwood K., Sacre S., Piccinini A. M., Inglis J., Trebaul A., Chan E., Drexler S., Sofat N., Kashiwagi M., Orend G., Brennan F., Foxwell B., Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease Nature Medicine 2009 15 7 774 780
104. Erridge C., Endogenous ligands of TLR2 and TLR4: agonists or assistants? Journal of Leukocyte Biology 2010 87 6 989 999
105. Sims G. P., Rowe D. C., Rietdijk S. T., Herbst R., Coyle A. J., HMGB1 and RAGE in inflammation and cancer Annual Review of Immunology 2010 28 367 388
106. Ellerman J. E., Brown C. K., de Vera M., Zeh H. J., Billiar T., Rubartelli A., Lotze M. T., Masquerader: high mobility group box-1 and cancer Clinical Cancer Research 2007 13 10 2836 2848 (Pubitemid 46850704)
107. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., Mignot G., Maiuri M. C., Ullrich E., Saulnier P., Yang H., Amigorena S., Ryffel B., Barrat F. J., Saftig P., Levi F., Lidereau R., Nogues C., Mira J. P., Chompret A., Joulin V., Clavel-Chapelon F., Bourhis J., André F., Delaloge S., Tursz T., Kroemer G., Zitvogel L., Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy Nature Medicine 2007 13 9 1050 1059 (Pubitemid 47517504)
108. Youn J. H., Oh Y. J., Kim E. S., Choi J. E., Shin J. S., High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF- production in human monocytes Journal of Immunology 2008 180 7 5067 5074
109. Tsan M.-F., Heat shock proteins and high mobility group box 1 protein lack cytokine function Journal of Leukocyte Biology 2011 89 6 247 852
110. Hreggvidsdottir H. S., stberg T., Whmaa H., Schierbeck H., Aveberger A.-C., Klevenvall L., Palmblad K., Ottosson L., Andersson U., Harris H. E., The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation Journal of Leukocyte Biology 2009 86 3 655 662
111. Lee H. K., Dunzendorfer S., Soldau K., Tobias P. S., Double-stranded RNA-mediated TLR3 activation is enhanced by CD14 Immunity 2006 24 2 153 163 (Pubitemid 43214585)
112. Baumann C. L., Aspalter I. M., Sharif O., Pichlmair A., Blml S., Grebien F., Bruckner M., Pasierbek P., Aumayr K., Planyavsky M., Bennett K. L., Colinge J., Knapp S., Superti-Furga G., CD14 is a coreceptor of Toll-like receptors 7 and 9 Journal of Experimental Medicine 2010 207 12 2689 2701
113. Wright S. D., Ramos R. A., Tobias P. S., Ulevitch R. J., Mathison J. C., CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein Science 1990 249 4975 1431 1433
114. Kadowaki N., Ho S., Antonenko S., De Waal Malefyt R., Kastelein R. A., Bazan F., Liu Y. J., Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens Journal of Experimental Medicine 2001 194 6 863 869 (Pubitemid 32983021)
115. Blander J. M., Medzhitov R., Toll-dependent selection of microbial antigens for presentation by dendritic cells Nature 2006 440 7085 808 812
116. West M. A., Wallin R. P. A., Matthews S. P., Svensson H. G., Zaru R., Ljunggren H. G., Prescott A. R., Watts C., Enhanced dendritic cell antigen capture via Toll-like receptor-induced actin remodeling Science 2004 305 5687 1153 1157 (Pubitemid 39100328)
117. Garrett W. S., Chen L. M., Kroschewski R., Ebersold M., Turley S., Trombetta S., Galn J. E., Mellman I., Developmental control of endocytosis in dendritic cells by Cdc42 Cell 2000 102 3 325 334
118. Blander J. M., Medzhitov R., Regulation of phagosome maturation by signals from Toll-like receptors Science 2004 304 5673 1014 1018 (Pubitemid 38638100)
119. Steinman R. M., Banchereau J., Taking dendritic cells into medicine Nature 2007 449 7161 419 426 (Pubitemid 47509552)
120. Andrews D. M., Scalzo A. A., Yokoyama W. M., Smyth M. J., Degli-Esposti M. A., Functional interactions between dendritic cells and NK cells during viral infection Nature Immunology 2003 4 2 175 181 (Pubitemid 36193020)
121. Pham T. N. N., Hong C. Y., Min J. J., Rhee J. H., Nguyen T. A. T., Park B. C., Yang D. H., Park Y. K., Kim H. R., Chung I. J., Kim H. J., Lee J. J., Enhancement of antitumor effect using dendritic cells activated with natural killer cells in the presence of Toll-like receptor agonist Experimental and Molecular Medicine 2010 42 6 407 419
122. Sylvester R. J., Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer International Journal of Urology 2011 18 2 113 120
123. Tsuji S., Matsumoto M., Takeuchi O., Akira S., Azuma I., Hayashi A., Toyoshima K., Seya T., Maturation of human dendritic cells by cell wall skeleton of Mycobacterium boris bacillus Calmette-Guérin: involvement of Toll-like receptors Infection and Immunity 2000 68 12 6883 6890 (Pubitemid 32463398)
124. Roux S., Apetoh L., Chalmin F., Ladoire S., Mignot G., Puig P. E., Lauvau G., Zitvogel L., Martin F., Chauffert B., Yagita H., Solary E., Ghiringhelli F., CD 4 + CD 25 + Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer Journal of Clinical Investigation 2008 118 11 3751 3761
125. Ryoma Y., Moriya Y., Okamoto M., Kanaya I., Saito M., Sato M., Biological effect of OK-432 (Picibanil) and possible application to dendritic cell therapy Anticancer Research 2004 24 5C 3295 3301 (Pubitemid 39390944)
126. Okamoto M., Oshikawa T., Tano T., Ohe G., Furuichi S., Nishikawa H., Ahmed S. U., Akashi S., Miyake K., Takeuchi O., Akira S., Moriya Y., Marsubara S., Ryoma Y., Saito M., Sato M., Involvement of Toll-like receptor 4 signaling in interferon- production and antitumor effect by streptococcal agent OK-432 Journal of the National Cancer Institute 2003 95 4 316 326 (Pubitemid 36336482)
127. Okamoto M., Oshikawa T., Tano T., Ahmed S. U., Kan S., Sasai A., Akashi S., Miyake K., Moriya Y., Ryoma Y., Saito M., Sato M., Mechanism of anticancer host response induced by OK-432, a streptococcal preparation, mediated by phagocytosis and Toll-like receptor 4 signaling Journal of Immunotherapy 2006 29 1 78 86
128. North R. J., Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells Journal of Experimental Medicine 1986 164 5 1652 1666 (Pubitemid 17184195)
129. Shigematsu A., Adachi Y., Koike-Kiriyama N., Suzuki Y., Iwasaki M., Koike Y., Nakano K., Mukaide H., Imamura M., Ikehara S., Effects of low-dose irradiation on enhancement of immunity by dendritic cells Journal of Radiation Research 2007 48 1 51 55 (Pubitemid 46219477)
130. Kim K. W., Kim S. H., Shin J. G., Kim G. S., Son Y. O., Park S. W., Kwon
131. Paulos C. M., Wrzesinski C., Kaiser A., Hinrichs C. S., Chieppa M., Cassard L., Palmer D. C., Boni A., Muranski P., Yu Z., Gattinoni L., Antony P. A., Rosenberg S. A., Restifo N. P., Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8 + T cells via TLR4 signaling Journal of Clinical Investigation 2007 117 8 2197 2204 (Pubitemid 47219564)
132. Kasturi S. P., Skountzou I., Albrecht R. A., Koutsonanos D., Hua T., Nakaya H. I., Ravindran R., Stewart S., Alam M., Kwissa M., Villinger F., Murthy N., Steel J., Jacob J., Hogan R. J., Garca-Sastre A., Compans R., Pulendran B., Programming the magnitude and persistence of antibody responses with innate immunity Nature 2011 470 7335 543 550
133. Garin A., Meyer-Hermann M., Contie M., Figge M. T., Buatois V., Gunzer M., Toellner K. M., Elson G., Kosco-Vilbois M. H., Toll-like receptor 4 signaling by follicular dendritic cells is pivotal for germinal center onset and affinity maturation Immunity 2010 33 1 84 95
134. El Shikh M. E. M., El Sayed R. M., Wu Y., Szakal A. K., Tew J. G., TLR4 on follicular dendritic cells: an activation pathway that promotes accessory activity Journal of Immunology 2007 179 7 4444 4450
135. Mata-Haro V., Cekic C., Martin M., Chilton P. M., Casella C. R., Mitchell T. C., The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4 Science 2007 316 5831 1628 1632 (Pubitemid 46982038)
136. Cluff C. W., Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results Advances in Experimental Medicine and Biology 2009 667 111 123